Repligen Stock Price

-4.64 (-2.64%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Repligen Corp RGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-4.64 -2.64% 171.20 17:15:19
Close Price Low Price High Price Open Price Previous Close
171.20 169.21 175.635 174.00 175.84
Bid Price Ask Price Spread News
171.21 174.01 2.80 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,899 285,252 $ 171.86 $ 49,022,964 366,566 76.85 - 180.8375
Last Trade Time Type Quantity Stock Price Currency
19:31:05 1 $ 171.50 USD

Repligen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.99B 52.50M 46.46M $ 270.25M $ 33.97M 0.44 306.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -986.00 4.80%

more financials information »

Repligen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week172.53180.8375169.21175.45324,850-1.33-0.77%
1 Month149.98180.8375145.27164.26396,98121.2214.15%
3 Months157.00180.8375138.00154.10364,58614.209.04%
6 Months119.54180.8375109.38135.49498,28951.6643.22%
1 Year79.24180.837576.85115.29485,59491.96116.05%
3 Years37.90180.837529.5682.38425,500133.30351.72%
5 Years32.77180.837520.0767.29365,610138.43422.43%

Repligen Description

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.